These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26558908)

  • 21. Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects.
    Son S; Lim SM; Chae SY; Kim K; Park EJ; Lee KC; Na DH
    Int J Pharm; 2015 Nov; 495(1):81-86. PubMed ID: 26325318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vesicular phospholipid gel-based depot formulations for pharmaceutical proteins: development and in vitro evaluation.
    Tian W; Schulze S; Brandl M; Winter G
    J Control Release; 2010 Mar; 142(3):319-25. PubMed ID: 19925833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model.
    Buchmann S; Sandmann GH; Walz L; Reichel T; Beitzel K; Wexel G; Tian W; Battmann A; Vogt S; Winter G; Imhoff AB
    BMC Musculoskelet Disord; 2015 Apr; 16():82. PubMed ID: 25888096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injectable and biodegradable phospholipid-based phase separation gel for sustained delivery of insulin.
    Zhang T; Luo J; Peng Q; Dong J; Wang Y; Gong T; Zhang Z
    Colloids Surf B Biointerfaces; 2019 Apr; 176():194-201. PubMed ID: 30616110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Once-weekly exenatide: an extended-duration glucagon-like peptide agonist for the treatment of type 2 diabetes mellitus.
    Minze MG; Klein MS; Jernigan MJ; Wise SL; Frugé K
    Pharmacotherapy; 2013 Jun; 33(6):627-38. PubMed ID: 23553357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and efficacy of a biweekly dosage formulation of exenatide in Zucker diabetic fatty (ZDF) rats.
    Kwak HH; Shim WS; Hwang S; Son MK; Kim YJ; Kim TH; Yoon ZH; Youn HJ; Lee GI; Kang SH; Shim CK
    Pharm Res; 2009 Nov; 26(11):2504-12. PubMed ID: 19756973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach.
    Soudry-Kochavi L; Naraykin N; Nassar T; Benita S
    J Control Release; 2015 Nov; 217():202-10. PubMed ID: 26381898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exenatide for type 2 diabetes.
    Garattini S; Bertele' V; Floriani I; Torri V
    Lancet; 2009 Jan; 373(9658):122; author reply 122-3. PubMed ID: 19135608
    [No Abstract]   [Full Text] [Related]  

  • 29. Exenatide extended-release: a once-weekly option for patients with type 2 diabetes.
    Anderson ZL; Clements JN
    JAAPA; 2014 Jun; 27(6):44-6. PubMed ID: 24853156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration.
    Cirincione B; Edwards J; Mager DE
    AAPS J; 2017 Mar; 19(2):487-496. PubMed ID: 27896683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes.
    He Z; Hu Y; Gui Z; Zhou Y; Nie T; Zhu J; Liu Z; Chen K; Liu L; Leong KW; Cao P; Chen Y; Mao HQ
    J Control Release; 2019 May; 301():119-128. PubMed ID: 30894322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of lactic acid acylated exenatide and its long-acting preparation.
    Wang A; Yan X; Liang R; Wang L; Chu L; Sun K; Fu F
    Pharm Dev Technol; 2019 Dec; 24(10):1229-1235. PubMed ID: 31368418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres.
    Li T; Chandrashekar A; Beig A; Walker J; Hong JKY; Benet A; Kang J; Ackermann R; Wang Y; Qin B; Schwendeman AS; Schwendeman SP
    Eur J Pharm Biopharm; 2021 Jan; 158():401-409. PubMed ID: 33122118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BÜCHI nano spray dryer B-90: a promising technology for the production of metformin hydrochloride-loaded alginate-gelatin nanoparticles.
    Shehata TM; Ibrahima MM
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1907-1914. PubMed ID: 31621436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Needle-Free Injection of Vesicular Phospholipid Gels-A Novel Approach to Overcome an Administration Hurdle for Semisolid Depot Systems.
    Breitsamer M; Winter G
    J Pharm Sci; 2017 Apr; 106(4):968-972. PubMed ID: 28041969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability.
    Qi F; Wu J; Fan Q; He F; Tian G; Yang T; Ma G; Su Z
    Colloids Surf B Biointerfaces; 2013 Dec; 112():492-8. PubMed ID: 24075786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetes.
    Aroda VR; DeYoung MB
    Postgrad Med; 2011 Sep; 123(5):228-38. PubMed ID: 21904106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
    Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
    Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults.
    Tzefos M; Harris K; Brackett A
    Ann Pharmacother; 2012 Jan; 46(1):68-78. PubMed ID: 22232377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained exenatide delivery via intracapsular microspheres for improved survival and function of microencapsulated porcine islets.
    Lew B; Kim IY; Choi H; Kim KK
    Drug Deliv Transl Res; 2018 Jun; 8(3):857-862. PubMed ID: 29372538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.